-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Amphastar Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2012 to 2023.
- Amphastar Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$9.37M, a 3.58% decline year-over-year.
- Amphastar Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$27.1M, a 183% decline year-over-year.
- Amphastar Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was -$25.6M, a 400% decline from 2022.
- Amphastar Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $8.54M, a 40.1% decline from 2021.
- Amphastar Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was $14.3M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)